The global glycomics market is projected to reach US$ 2.8 billion by 2028, driven by the growing prevalence of chronic conditions and the need for reliable biomarkers in diagnostics and therapeutic monitoring. The drug discovery outsourcing market is expected to reach over US$ 7.5 billion by 2031, fueled by increased R&D spending and a focus on personalized medicines and orphan drugs. The biologics drug development market is projected to grow exponentially by 2029, with prominent companies including Abbvie, Allergan, Boehringer Ingelheim, Charles River Laboratories, Catalent, Lonza Group, Amgen, and Sanofi. The South Africa biopharmaceuticals market is expected to reach $2.21 billion by 2028, driven by government support, advancements in medical research, and the growing prevalence of chronic diseases.

Biotechnology Market Projections